Superficial spreading melanoma prognosis

Superficial spreading melanoma can remain in the upper skin for a period before invading deeper tissue. A thinner tumour without ulceration generally gives clinicians a different starting point from a thicker or ulcerated tumour, but only your complete pathology and staging can describe your situation. The status of nearby lymph nodes and any distant spread also changes the care pathway. Brain metastases are one example of distant spread, but symptoms or a subtype name alone cannot establish that it has occurred.

Prognosis is a clinical estimate, not a promise about one person. It can be revised when surgery, imaging, lymph-node testing, or treatment provides new information. Your age, general health, tumour biology, and how the disease responds to therapy may also matter.

Ask for a clear explanation of the pathology stage and whether the primary lesion was fully removed. Depending on the findings, your team may discuss wider excision, sentinel lymph node biopsy, imaging, or systemic treatment. Keep appointments, bring your report and medication list, and examine your skin and lymph-node areas as advised. Follow-up after cancer treatment helps detect changes early and gives you a place to discuss anxiety, scars, and sun protection. Read more about Melanoma and Follow-Up After Cancer Treatment.

Report a new lump near the treated area, a changing spot, persistent unexplained pain, or ongoing swelling to your cancer team. Seek urgent help for severe breathlessness, sudden weakness, confusion, seizure, or a rapidly worsening severe headache. These symptoms have many possible causes, but prompt assessment matters after a melanoma diagnosis.

What is my stage and which finding contributes most to it? Was ulceration present? Were lymph nodes assessed? Do I need additional surgery or imaging? How will you monitor for recurrence, and which symptoms should trigger a call?